Increasing Rate of Unfilled Training Positions in the Advanced Heart Failure and Transplant Cardiology Match

Jason Silvestre1, Ahmed Brgdar2, Jay Chen2

  • 1Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

PubMed

Insights

Interest in Advanced Heart Failure and Transplant Cardiology (AHFTC) fellowship training is declining, with a significant increase in unfilled positions despite growing demand for heart failure specialists.

Area of Science:

  • Cardiology
  • Medical Education
  • Transplant Surgery

Background:

  • Advanced Heart Failure and Transplant Cardiology (AHFTC) is crucial for managing complex heart failure and performing advanced therapies.
  • Despite increasing clinical need, there's a concerning trend of declining interest in AHFTC fellowship programs.

Purpose of the Study:

  • To analyze trends in AHFTC fellowship applicants, training positions, match rates, and unfilled positions from 2020 to 2025.
  • To identify the gap between training capacity and applicant interest in AHFTC.

Main Methods:

  • A national, cross-sectional analysis of AHFTC fellowship match data from 2020 to 2025.
  • Evaluation of applicant numbers, training positions, match rates, and unfilled positions.
  • Linear regression analysis to assess temporal trends.

Main Results:

  • The number of AHFTC training positions increased by 10%, while applicants decreased by 24% between 2020 and 2025.
  • The applicant-to-position ratio dropped significantly, and unfilled positions more than doubled, rising from 30% to 52%.
  • Despite fewer applicants, the proportion matching at their first-choice program increased.

Conclusions:

  • A significant mismatch exists between AHFTC training capacity and applicant interest, characterized by increasing unfilled positions.
  • Urgent strategies are needed to stimulate interest in AHFTC training to ensure a future workforce for heart failure care.
  • The findings underscore the need for proactive measures to sustain and grow the AHFTC subspecialty.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
33